Department of Medicine, Lincoln Medical Center, New York, NY, USA.
Cebu Institute of Medicine, Cebu City, Philippines.
Heart Lung. 2024 Sep-Oct;67:144-151. doi: 10.1016/j.hrtlng.2024.05.003. Epub 2024 May 18.
Despite comprising almost half of all patients undergoing valvular repair, data on transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic stenosis (BAS) are limited.
We aimed to evaluate whether there are any sex differences in trends and outcomes of TAVR in this population.
We utilized the National Inpatient Sample from 2012 to 2020 to identify admissions with BAS who underwent TAVR and analyzed trends and outcomes. Our primary outcome was in-hospital mortality and secondary outcomes were in-hospital complications. We used two models to adjust for demographics (A) and interventions (B).
Between 2012 to 2020, there were 76,540 hospitalizations for BAS patients who underwent AVR, among which 6,010 (7.9 %) underwent TAVR. There was an overall increasing trend in number of TAVR cases with a decreasing trend in mortality (2013: 8.7 %, 2020: 1.3 %). TAVR was performed more in males (61.1% vs 38.9 %). Despite the worse baseline characteristics in males, in-hospital mortality (2.4% vs. 1.5 %; OR: 1.584; 95 % CI: 0.621-4.038; p = 0.335) and secondary outcomes were similar across both sexes, even after adjusting for demographics and interventions.
TAVR in BAS has grown rapidly in the last decade. Males comprised the majority and had more comorbidities, but mortality and complications were similar in both sexes. Despite the increasing number of cases, a decreasing trend in mortality was observed for both sexes ultimately approaching that of SAVR, suggesting that TAVR may be a safe alternative among eligible males and females with bicuspid AS.
尽管在接受瓣膜修复的所有患者中,二叶式主动脉瓣狭窄(BAS)患者约占一半,但关于经导管主动脉瓣置换术(TAVR)的数据有限。
我们旨在评估在该人群中,TAVR 的趋势和结果是否存在任何性别差异。
我们利用 2012 年至 2020 年的全国住院患者样本,确定接受 BAS 并接受 TAVR 的患者入院情况,并分析了趋势和结果。我们的主要结局是住院死亡率,次要结局是住院并发症。我们使用两种模型(A)和干预措施(B)来调整人口统计学因素。
在 2012 年至 2020 年期间,共有 76540 例 BAS 患者接受了 AVR 治疗,其中 6010 例(7.9%)接受了 TAVR。TAVR 病例数量呈总体增加趋势,死亡率呈下降趋势(2013 年:8.7%,2020 年:1.3%)。TAVR 更多地用于男性(61.1%对 38.9%)。尽管男性的基线特征较差,但住院死亡率(2.4%对 1.5%;比值比:1.584;95%置信区间:0.621-4.038;p=0.335)和次要结局在两性之间相似,即使在调整了人口统计学因素和干预措施后也是如此。
在过去十年中,BAS 的 TAVR 迅速发展。男性占多数,合并症更多,但两性的死亡率和并发症相似。尽管病例数量增加,但两性的死亡率呈下降趋势,最终接近 SAVR,这表明 TAVR 可能是二叶式主动脉瓣狭窄的合格男性和女性的一种安全替代方法。